D
Unicycive Therapeutics, Inc. UNCY
$4.23 -$0.02-0.47% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -1,231.05% 102.65% -425.51% -141.56% 147.01%
Total Depreciation and Amortization 2.22% 0.75% 8.94% 208.85% -139.79%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 102.53% -159.24% 1,243.69% 92.89% -231.14%
Change in Net Operating Assets -26.60% -207.11% 141.21% -3,924.07% -94.29%
Cash from Operations 5.43% -35.97% 29.23% -46.42% 2.12%
Capital Expenditure 62.50% 27.27% 8.33% -20.00% -233.33%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing 62.50% 27.27% 8.33% -20.00% -233.33%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 306.09% 308.49% -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- -100.00%
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- 100.00% --
Other Financing Activities -41.80% 23.27% -102.55% -155.28% 106.59%
Cash from Financing 331.42% 597.53% 332.48% 80.64% -101.77%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 140.14% -2.71% 34.22% -31.93% -118.23%